Elekta Valuation

Q: What is the Fair Price of 0O5H when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

0O5H (SEK62.75) is trading below our estimate of [[fair value]] (SEK116.93)

Is 0O5H undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0O5H when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow

Simply Wall St

SEK 116.93

Fair Value

46.3% undervalued

Number of Analysts

Below Fair Value: 0O5H (SEK62.75) is trading below our estimate of fair value (SEK116.93)

Significantly Below Fair Value: 0O5H is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0O5H?

Key metric: As 0O5H is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0O5H. This is calculated by dividing 0O5H's market cap by their current earnings.
What is 0O5H's PE Ratio?
PE Ratio	23.9x
Earnings	SEK 1.00b
Market Cap	SEK 23.98b

0O5H key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.7x
Enterprise Value/EBITDA	15.5x
PEG Ratio	1.1x

Price to Earnings Ratio vs Peers

How does 0O5H's PE Ratio compare to its peers?

The above table shows the PE ratio for 0O5H vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	29.4x
SN. Smith & Nephew	34.5x	22.6%	UK£8.6b
NIOX NIOX Group	21.1x	15.8%	UK£232.4m
EKF EKF Diagnostics Holdings	25.2x	n/a	UK£120.2m
CTEC ConvaTec Group	36.6x	20.3%	UK£4.6b
0O5H Elekta	23.9x	21.3%	SEK 24.0b

Price-To-Earnings vs Peers: 0O5H is good value based on its Price-To-Earnings Ratio (23.9x) compared to the peer average (29.4x).

Price to Earnings Ratio vs Industry

How does 0O5H's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 0O5H is good value based on its Price-To-Earnings Ratio (23.9x) compared to the European Medical Equipment industry average (31.1x).

Price to Earnings Ratio vs Fair Ratio

What is 0O5H's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0O5H PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	23.9x
Fair PE Ratio	35.5x

Price-To-Earnings vs Fair Ratio: 0O5H is good value based on its Price-To-Earnings Ratio (23.9x) compared to the estimated Fair Price-To-Earnings Ratio (35.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0O5H forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	SEK 62.75	SEK 72.92 +16.2%	27.7%	SEK 127.00	SEK 51.50	n/a	13
Jan ’26	SEK 60.94	SEK 73.38 +20.4%	27.1%	SEK 127.00	SEK 51.50	n/a	13
Dec ’25	SEK 65.05	SEK 74.12 +13.9%	26.0%	SEK 127.00	SEK 57.00	n/a	13
Nov ’25	SEK 64.55	SEK 76.36 +18.3%	23.6%	SEK 127.00	SEK 57.00	n/a	14
Oct ’25	SEK 72.00	SEK 76.21 +5.9%	23.8%	SEK 127.00	SEK 57.00	n/a	14
Sep ’25	SEK 70.12	SEK 76.69 +9.4%	24.7%	SEK 127.00	SEK 57.00	n/a	13
Aug ’25	SEK 66.52	SEK 76.31 +14.7%	24.9%	SEK 127.00	SEK 57.00	n/a	13
Jul ’25	SEK 65.80	SEK 76.38 +16.1%	24.7%	SEK 127.00	SEK 57.00	n/a	13
Jun ’25	SEK 85.94	SEK 84.08 -2.2%	24.4%	SEK 127.00	SEK 57.00	n/a	12
May ’25	SEK 79.20	SEK 83.42 +5.3%	24.5%	SEK 127.00	SEK 57.00	n/a	12
Apr ’25	SEK 80.47	SEK 86.00 +6.9%	23.7%	SEK 127.00	SEK 57.00	n/a	12
Mar ’25	SEK 77.19	SEK 86.33 +11.8%	23.4%	SEK 127.00	SEK 57.00	n/a	12
Feb ’25	SEK 78.35	SEK 86.67 +10.6%	23.4%	SEK 127.00	SEK 57.00	n/a	12
Jan ’25	SEK 82.39	SEK 84.73 +2.8%	23.3%	SEK 127.00	SEK 57.00	SEK 60.94	11
Dec ’24	SEK 81.83	SEK 84.91 +3.8%	23.7%	SEK 127.00	SEK 57.00	SEK 65.05	11
Nov ’24	SEK 75.28	SEK 82.00 +8.9%	26.2%	SEK 127.00	SEK 53.00	SEK 64.55	11
Oct ’24	SEK 75.13	SEK 83.30 +10.9%	26.6%	SEK 127.00	SEK 53.00	SEK 72.00	10
Sep ’24	SEK 77.63	SEK 83.30 +7.3%	26.6%	SEK 127.00	SEK 53.00	SEK 70.12	10
Aug ’24	SEK 85.31	SEK 83.20 -2.5%	26.2%	SEK 127.00	SEK 57.00	SEK 66.52	10
Jul ’24	SEK 83.34	SEK 85.50 +2.6%	26.0%	SEK 127.00	SEK 57.00	SEK 65.80	10
Jun ’24	SEK 81.35	SEK 83.40 +2.5%	25.5%	SEK 127.00	SEK 57.00	SEK 85.94	10
May ’24	SEK 85.51	SEK 81.22 -5.0%	28.3%	SEK 127.00	SEK 57.00	SEK 79.20	10
Apr ’24	SEK 79.13	SEK 81.22 +2.6%	28.3%	SEK 127.00	SEK 57.00	SEK 80.47	10
Mar ’24	SEK 81.26	SEK 77.91 -4.1%	28.7%	SEK 127.00	SEK 57.00	SEK 77.19	9
Feb ’24	SEK 76.79	SEK 73.67 -4.1%	31.5%	SEK 127.00	SEK 52.00	SEK 78.35	9
Jan ’24	SEK 64.25	SEK 70.44 +9.6%	31.8%	SEK 127.00	SEK 52.00	SEK 82.39	9

Analyst Price Target

Consensus Narrative from 13 Analysts

SEK 72.92

Fair Value

14.0% undervalued

Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 02:32
End of Day Share Price	2025/01/10 00:00
Earnings	2024/10/31
Annual Earnings	2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elekta AB (publ) is covered by 39 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sumit Sayal	AlphaValue
Alexander Kleban	Barclays
Hassan Al-Wakeel	Barclays